155 related articles for article (PubMed ID: 28069049)
1. Dedifferentiated endometrioid carcinoma of the uterus : report of four cases and review of literature.
Han J; Ki EY; Rha SE; Hur S; Lee A
World J Surg Oncol; 2017 Jan; 15(1):17. PubMed ID: 28069049
[TBL] [Abstract][Full Text] [Related]
2. Dedifferentiated endometrioid adenocarcinoma of the uterus: a case report.
Soyama H; Takano M; Miyamoto M; Kato M; Goto T; Furuya K
Eur J Gynaecol Oncol; 2016; 37(3):426-9. PubMed ID: 27352580
[TBL] [Abstract][Full Text] [Related]
3. Association of low-grade endometrioid carcinoma of the uterus and ovary with undifferentiated carcinoma: a new type of dedifferentiated carcinoma?
Silva EG; Deavers MT; Bodurka DC; Malpica A
Int J Gynecol Pathol; 2006 Jan; 25(1):52-8. PubMed ID: 16306785
[TBL] [Abstract][Full Text] [Related]
4. Dedifferentiated endometrioid adenocarcinoma of the uterus: a clinicopathologic study of a case.
Vita G; Borgia L; Di Giovannantonio L; Bisceglia M
Int J Surg Pathol; 2011 Oct; 19(5):649-52. PubMed ID: 21531695
[TBL] [Abstract][Full Text] [Related]
5. A report of two cases of dedifferentiated endometrioid carcinoma: A newly described underrecognized tumor of poor prognosis.
Boler AK; Akhtar S; Bandyopadhyay A; Roy S
Indian J Pathol Microbiol; 2020 Feb; 63(Supplement):S91-S93. PubMed ID: 32108637
[TBL] [Abstract][Full Text] [Related]
6. Lymphatic invasion according to D2-40 immunostaining is a predictor of nodal metastasis in endometrioid adenocarcinoma of the uterine corpus.
Miyakuni Y; Matsumoto T; Arakawa A; Sonoue H; Suzuki C; Takeda S
Pathol Int; 2008 Aug; 58(8):471-6. PubMed ID: 18705765
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathologic study of endometrial dedifferentiated endometrioid adenocarcinoma: a case report.
Shen Y; Wang Y; Shi Y; Liu J; Liu Y
Int J Clin Exp Pathol; 2012; 5(1):77-82. PubMed ID: 22295150
[TBL] [Abstract][Full Text] [Related]
8. Androgen Receptor Immunohistochemical Expression in Undifferentiated/Dedifferentiated Endometrial Carcinoma.
Cao J; Hacking S; Chavarria-Bernal HD; Bhuiya TA; Khutti S
Int J Gynecol Pathol; 2022 Jan; 41(1):28-34. PubMed ID: 33399351
[TBL] [Abstract][Full Text] [Related]
9. Pattern of SMARCB1 (INI1) and SMARCA4 (BRG1) in poorly differentiated endometrioid adenocarcinoma of the uterus: analysis of a series with emphasis on a novel SMARCA4-deficient dedifferentiated rhabdoid variant.
Strehl JD; Wachter DL; Fiedler J; Heimerl E; Beckmann MW; Hartmann A; Agaimy A
Ann Diagn Pathol; 2015 Aug; 19(4):198-202. PubMed ID: 25920939
[TBL] [Abstract][Full Text] [Related]
10. Dedifferentiated endometrioid adenocarcinoma; clinicopathologic and immunohistochemical features of five cases.
Yiğit S; Ekinci N; Hayrullah L; Öcal İ; Bezircioğlu İ
J Turk Ger Gynecol Assoc; 2018 Aug; 19(3):132-136. PubMed ID: 29545232
[TBL] [Abstract][Full Text] [Related]
11. Uterine papillary serous carcinoma pre-operatively diagnosed as endometrioid carcinoma: Is omentectomy necessary?
Peled Y; Aviram A; Krissi H; Gershoni A; Sabah G; Levavi H; Eitan R
Aust N Z J Obstet Gynaecol; 2015 Oct; 55(5):498-502. PubMed ID: 26235227
[TBL] [Abstract][Full Text] [Related]
12. An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer.
Gadducci A; Cosio S; Fanucchi A; Cristofani R; Genazzani AR
Anticancer Res; 2000; 20(3B):1977-84. PubMed ID: 10928137
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathologic and Immunohistochemical Characterization of Dedifferentiated Endometrioid Adenocarcinoma.
Li Z; Zhao C
Appl Immunohistochem Mol Morphol; 2016 Sep; 24(8):562-8. PubMed ID: 26371430
[TBL] [Abstract][Full Text] [Related]
14. Progesterone receptor negativity is an independent risk factor for relapse in patients with early stage endometrioid endometrial adenocarcinoma.
Huvila J; Talve L; Carpén O; Edqvist PH; Pontén F; Grénman S; Auranen A
Gynecol Oncol; 2013 Sep; 130(3):463-9. PubMed ID: 23777659
[TBL] [Abstract][Full Text] [Related]
15. Endometrioid carcinoma simultaneously involving the uterus and the fallopian tube: a clinicopathologic study of 13 cases.
Culton LK; Deavers MT; Silva EG; Liu J; Malpica A
Am J Surg Pathol; 2006 Jul; 30(7):844-9. PubMed ID: 16819326
[TBL] [Abstract][Full Text] [Related]
16. Low-grade endometrioid carcinoma of the ovary associated with undifferentiated carcinoma: case report and review of the literature.
Chen L; Pang S; Shen Y; Liu Z; Luan J; Shi Y; Liu Y
Int J Clin Exp Pathol; 2014; 7(7):4422-7. PubMed ID: 25120828
[TBL] [Abstract][Full Text] [Related]
17. [Expression and significance of Twist1 and MMP-2 in endometrial endometrioid adenocarcinoma].
Wang XJ; Chen XH
Zhonghua Zhong Liu Za Zhi; 2012 Aug; 34(8):588-91. PubMed ID: 23158991
[TBL] [Abstract][Full Text] [Related]
18. Endometrioid adenocarcinoma of the uterus with a minimal deviation invasive pattern.
Landry D; Mai KT; Senterman MK; Perkins DG; Yazdi HM; Veinot JP; Thomas J
Histopathology; 2003 Jan; 42(1):77-82. PubMed ID: 12493029
[TBL] [Abstract][Full Text] [Related]
19. The expression of cadherin e and clinical prognostic factors in uterine endometrioid adenocarcinoma.
Dvalishvili I; Charkviani L; Turashvili G; Burkadze G
Georgian Med News; 2005 Nov; (128):17-21. PubMed ID: 16369055
[TBL] [Abstract][Full Text] [Related]
20. Dedifferentiated endometrioid adenocarcinoma of the uterus: A case series and review of literature.
Goh C; Farah BL; Ho WY; Wong SL; Goh CHR; Chew SH; Nadarajah R; Lim YK; Ho TH
Gynecol Oncol Rep; 2020 May; 32():100538. PubMed ID: 32090165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
